MétaCan
Menu
Back to cohort

Abstract A015: Retinoblastoma points to solutions for Early-Onset Cancers

2025· article· en· W4417201104 on OpenAlexaffabout
Brenda Gallie, Kaitlyn Flegg, Kelvin Chau

Bibliographic record

VenueClinical Cancer Research · 2025
Typearticle
Languageen
FieldMedicine
TopicRetinopathy of Prematurity Studies
Canadian institutionsSickKids FoundationPublic Health OntarioPrincess Margaret Cancer Centre
Fundersnot available
KeywordsRetinoblastomaCancerChildhood cancerClinical trialDiseaseIncidence (geometry)Childhood blindness

Abstract

fetched live from OpenAlex

Abstract Retinoblastoma exists in two starkly different worlds. In our high-income world, >95% of children survive useful vision. In the darker low- and middle-income countries (LMICs), 30% survive with often poor or no vision. Retinoblastoma is the same nasty cancer of infant retina where ever the child lives. The World Health Organization Global Initiative for Childhood Cancer prioritized retinoblastoma as a key indicator because of profound inequity in survival, depending on where the child lives. The 2017 cancer stage includes “H1” for persons with a damaged tumor suppressor RB1 gene, which carries a high risk of retinoblastoma and subsequent malignant neoplasms (SMN). Canadian familial H1 infants are delivered early term, when 30% already have retinal tumors that can be cured with simple therapy, saving vision, eyes, and life. Early identification of H1 persons with other cancer predisposition syndromes will contribute to appropriate monitoring and early low morbidity treatment, but also increase the incidence of early onset cancers. The eCancerCareRB database (only inside SickKids) includes a timeline displaying all treatment events, a key tool in patient care. A potentially “game-changing” clinical trial of Chemoplaque (sustained release 6 weeks of topotecan to the eye only) used our novel SwimmerMatch analysis tool to compare Chemoplaque participants to propensity-matched eCancerCareRB patients, showing improved recurrence-free eye survival (p-value 0.0002, log rank test). Since eCancerCareRB is ONLY inside SickKids, we built cloud-based DEPICT HEALTH (DEPICT) to connect global retinoblastoma care centers worldwide. Families view their DEPICT data. Real-time DEPICT access to clinical data and treatments empowers active family participation in care, a full view for life. Regions/countries will have point-of-care DEPICT data in support of transformative National Guidelines relevant to their financial and technical realities, for them to be ready for the demonstrated increase in incidence of early onset cancers. The World Health Organization's prioritization of retinoblastoma as a key indicator is achieving global cooperation that will be assisted by DEPICT HEALTH. Just as rare retinoblastoma first pointed out that cancer is a genomic disease, these novel clinical trial global data of DEPICT and its analysis tools can be a prototype for any cancer worldwide. Citation Format: Brenda Gallie, Kaitlyn Flegg, Kelvin Chau. Retinoblastoma points to solutions for Early-Onset Cancers [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers—Knowledge Gaps and Research Opportunities; 2025 Dec 10-13; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(23_Suppl):Abstract nr A015.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.010
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.751
Threshold uncertainty score0.998

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0050.010
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0010.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.291
GPT teacher head0.568
Teacher spread0.277 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueClinical Cancer ResearchSame topicRetinopathy of Prematurity StudiesFrench-language works237,207